Western Europe’s Fashion E-commerce Market Matures, Representing 20% of Online Consumer Spending as Gen Z Drives momentum July 30, 2026 Second-hand platforms and value-focused retailers are disrupting Western Europe’s fashion market, which accounts for nearly one-fifth of online spending
Arch Construction Risk Report Reveals Top Challenges Facing Sector Amid Rising Volatility July 30, 2026 Growing complexity and interconnected risks driving up insurance spend in construction.
Fluidra Delivers a Strong First Half of 2026 and Maintains Positive Momentum in a Dynamic Environment July 30, 2026 Sales increased by 5% at constant FX to €1,258 million, driven by Fluidra’s customer focus and consistent execution Adjusted EBITDA grew by 6% at constant FX to €321 million, supported by firm cost discipline The company signed an agreement to acquire Hydrapro, a French manufacturer specializing in water treatment, to further support its growth Fluidra launches a €40 million share buy-back program and maintains full-year guidance
Iksuda receives US FDA IND clearance for IKS04 July 30, 2026 CA242-directed ADC approved for assessment in Phase 1 trials in patients with GI cancers The ‘IKS04 Regimen’ is an innovative dosing approach for an ADC which is employed to overcome the challenge of solid tumour penetration for high-potency payloads
SES Reports H1 2026 Results & Reiterates Full-Year Outlook July 30, 2026 SES S.A. announces financial results for the three and six months ended June 30, 2026. H1 2026 Performance (€ million) H1 2026 as reported (1) H1 2025 as reported (1) ∆ At constant FX (2) H1 2025 like-for-like(3) ∆ At constant FX (2) Average €/$ FX rate 1.17 1.08 1.08 Revenue 1,602 978 [...]
AB InBev Reports Second Quarter 2026 Results July 30, 2026 Solid top- and bottom-line performance: Revenue up by 5.6%, Beer volume growth of 1.1% and a 23.4% Underlying EPS increase
KBRA Assigns Preliminary Ratings to Barings Euro Middle Market 2024-1 (Reset) July 29, 2026 KBRA UK (KBRA) assigns preliminary ratings to seven classes of notes issued by Barings Euro Middle Market 2024-1 (Reset), a cash flow collateralized loan obligation (CLO) backed by a diversified portfolio of middle market corporate loans. The original transaction closed on 16 December 2024 as a static CLO. This transaction refinances the original CLO by [...]
Everest Reports Second Quarter 2026 Results July 29, 2026 Annualized 14.2% Net Income ROE and 14.9% Net Operating Income ROE Annualized Total Shareholder Return of 16.8% $559 million of Net Income and Combined Ratio of 92.0% $317 million of Underwriting Income and Combined Ratio of 90.0% from our Core Businesses* Repurchased $395 million of Common Shares During the Quarter
Arm Holdings plc Reports Results for the First Quarter of the Fiscal Year Ending 2027 July 29, 2026 Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has today published a letter to its shareholders containing the company’s results for its first quarter of fiscal year 2027, which ended June 30, 2026. The letter is available on its investor relations website (https://investors.arm.com/financials/quarterly-annual-results). The shareholder letter will also be [...]
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 July 29, 2026 Superiority data from LATA, together with OPERA findings, add to the clinical and real-world evidence base for long-acting injectable Cabenuva Six-month follow-up CLARITY data further reinforce a more favourable injection experience with long-acting cabotegravir compared with lenacapavir after a single dose; additional studies showcase high real-world adherence and a preference for Apretude among previous oral PrEP users EXTEND 4M explores a new investigational intramuscular cabotegravir formulation dosed three times a year for HIV prevention, as part of broader long-acting pipeline data
